Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACYW booster and immune persistence study in children and adolescents previously primed as toddlers
2021-000104-38Phase 3Active
- Sponsor
- Sanofi
- Start
- May 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of Meningococcal ACWY conjugate vaccine in meningococcal disease (3 arms), sponsored by Sanofi. Primary endpoint: Vaccine seroresponse against meningococcal serogroups A, C, W, and Y. Started May 2021; status: active.
02
Drugs
Meningococcal ACWY conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2021-000104-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000104-38.